Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
1.530
-0.160 (-9.47%)
At close: Nov 1, 2024, 4:00 PM
1.560
+0.030 (1.96%)
After-hours: Nov 1, 2024, 5:45 PM EDT

Taysha Gene Therapies Revenue

Taysha Gene Therapies had revenue of $1.11M in the quarter ending June 30, 2024, a decrease of -53.57%. This brings the company's revenue in the last twelve months to $12.87M, up 34.05% year-over-year. In the year 2023, Taysha Gene Therapies had annual revenue of $15.45M with 517.55% growth.

Revenue (ttm)
$12.87M
Revenue Growth
+34.05%
P/S Ratio
23.80
Revenue / Employee
$247,558
Employees
52
Market Cap
313.56M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202315.45M12.95M517.55%
Dec 31, 20222.50M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OraSure Technologies 273.54M
Aurora Cannabis 203.84M
Treace Medical Concepts 198.53M
Spok Holdings 137.71M
Jin Medical International 20.13M
AC Immune 17.24M
Revenue Rankings